Japan Tissue Engineering Co., Ltd.

7774・Growth Market・Precision Instruments

Official website

Japan Tissue Engineering Co., Ltd.

7774・Growth Market・Precision Instruments

Official website

Japan Tissue Engineering Co., Ltd.7774

Reference Indicators

Market Cap

253¥100M

P/E (Forecast)

252.8x

P/B

5.0x

Dividend Yield (Forecast)

0.00%

ROE

-14.4%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	2,103	2,032	2,514	2,455	2,182
Cost of Sales	847	895	823	944	915
Gross Profit	1,255	1,136	1,690	1,511	1,267
SG&A Expenses	1,753	1,864	1,546	1,749	1,816
Operating Income	-498	-728	144	-238	-549
Non-operating Income	5	3	3	4	13
Non-operating Expenses	1	1	0	0	1
Ordinary Income	-494	-725	147	-234	-537
Extraordinary Income	—	—	130	10	31
Extraordinary Losses	—	—	130	10	225
Pre-tax Income	-494	-725	147	-234	-730
Income Taxes	3	3	3	20	3
Net Income	-497	-729	143	-255	-734
EBITDA	-373	-596	278	-79	-392
Gross Margin	59.7%	55.9%	67.2%	61.5%	58.1%
Operating Margin	-23.7%	-35.8%	5.7%	-9.7%	-25.2%
ROA	-6.6%	-10.6%	2.0%	-3.9%	-12.9%
ROE	-7.5%	-12.3%	2.4%	-4.4%	-14.4%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
再生医療製品事業	1,354	78	5.8%
再生医療受託事業	546	327	59.9%
ラボサイト事業	281	52	18.5%